Sign in

CIK 0001655923 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Alpha Cognition Inc.

Sign in to watch
Ticker
ACOG
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(858) 344-4375
Business address
1452 HUGHES RD., STE. 200, GRAPEVINE, TX, 76051
Former names
Neurodyn Cognition Inc.
  1. 10-Q Report Quarterly Report
  2. 4 Open-market buy 10% owner bought 32,090 shares at an average $8.28 ($265,820)
  3. 4 Open-market buy 10% owner bought 36,940 shares at an average $8.35 ($308,576)
  4. 4 Open-market buy 10% owner bought 19,050 shares at $8.69 ($165,634)
  5. 4 Open-market buy 10% owner bought 31,763 shares at an average $8.53 ($270,800)
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. 4 Open-market buy 10% owner bought 123,918 shares at an average $8.57 ($1,062,506)
  8. 4 Open-market buy Director bought 10,000 shares at $9.62 ($96,200)
  9. 10-Q Report Quarterly Report
  10. 4 Open-market buy 10% owner bought 52,900 shares at an average $8.00 ($422,976)
  11. 4 Open-market buy 10% owner bought 130 shares at $7.90 ($1,027)
  12. 4 Open-market buy 10% owner bought 200,086 shares at an average $7.82 ($1,565,499)
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 4 Open-market buy 10% owner bought 152,533 shares at an average $6.40 ($976,490)
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 8-K Event Executive or director change · Shareholder vote results
  17. 4 Open-market buy 10% owner bought 7,685 shares at an average $5.96 ($45,773)
  18. 4 Open-market buy 10% owner bought 30,728 shares at an average $5.98 ($183,692)
  19. 4 Open-market buy 10% owner bought 10,054 shares at $5.83 ($58,596)
  20. 4 Open-market buy 10% owner bought 73,738 shares at an average $5.90 ($434,714)

Page 1 of 11 · 217 filings